Lidocaine pharmacokinetics in children during general anesthesia.
D A Finholt, J A Stirt, C A DiFazio...
https://pubmed.ncbi.nlm.nih.gov/3954094/Actively Recruiting
Led by Nemours Children's Clinic · Updated on 2026-07-06
90
Participants Needed
1
Research Sites
30 weeks
Total Duration
Researchers are evaluating whether giving children intravenous lidocaine during surgery can reduce the amount of opioid pain medicine needed and improve pain control after surgery. This randomized, double-blind trial involves children aged 3 to 18 years undergoing surgery to fix upper arm bone fractures under general anesthesia. The study aims to find safer ways to manage pain using fewer opioids during pediatric orthopedic procedures. Participants will be randomly assigned to receive either a lidocaine infusion or a placebo normal saline during their surgery. All children will receive standard anesthesia and pain care afterward. The study will compare total opioid use within 60 minutes after arrival in the recovery room between the two groups. Additional measures include pain scores at various times, length of recovery room stay, use of anti-nausea medication, and how infusion duration relates to outcomes. During the study, children will be closely watched for any side effects or signs of lidocaine toxicity. Researchers will collect data on opioid consumption and pain levels during and after surgery. The primary focus is on opioid use in the first hour after surgery. The study will continue through the recovery period, monitoring safety and effectiveness, with participation lasting from surgery through early recovery.
CONDITIONS
A Clinical Trial on the Use of Lidocaine Infusion During Surgery for Pediatric Upper Extremity Fractures and Its Impact on Total Perioperative Opioid Requirements
A
Angela Snow, MD
I
Isabela Santiago, BS
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Nemours Children's Clinic
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Lidocaine Infusion During Surgery | Placebo Infusion During Surgery | Standard Perioperative Opioid Analgesia |
|---|---|---|---|
| What is it? | Children receive an intravenous infusion of lidocaine during surgery for upper extremity fractures. | Children receive a placebo infusion during surgery for upper extremity fractures. | Children undergoing upper extremity fracture surgery typically receive perioperative opioid analgesics for pain management. |
| Role in the trial | Investigational therapy. Assessed for its effect on perioperative opioid requirement. | Comparator arm. Used to measure effectiveness of lidocaine in reducing opioid use. | Routine care outside the study, representing current standard approach. |
| Primary use | Examined for reducing perioperative opioid consumption and post-surgical pain. | Used as a baseline comparison to measure lidocaine's impact. | Relieves pain using opioid medications after fracture surgery. |
| How it is given or performed | Intravenous infusion administered during surgery. | Comparison group receives an identical intravenous infusion with inactive solution during surgery. | IV or oral opioids are delivered post-surgery based on pain needs. |
| Evidence status | Ongoing randomized trial will establish lidocaine's impact on opioid use in this surgery context. External meta-analyses show lidocaine can reduce postoperative pain and opioid need in pediatric and adult surgery, but effect size and safety vary. | Serves as control. No additional pain reduction benefit is expected over standard practice. | Current evidence shows most children undergoing fracture surgery require opioid analgesics for perioperative pain control. Dosing and duration vary by type of procedure and patient factors. |
| Important limitations | Lidocaine infusion carries risks of dose-related toxicity, cardiac arrhythmia, and adverse events, especially in children with underlying conditions. The benefit for opioid reduction may differ across surgeries and ages. | Does not reduce pain or opioid requirement beyond standard practice. | Opioid analgesia is effective but can cause side effects including nausea, sedation, constipation, and rare respiratory depression. Risk of overprescribing and variability in post-discharge use are noted in pediatric fracture patients. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Surgery day
Participants receive either intravenous lidocaine infusion or placebo during surgery under general anesthesia. Standard anesthesia and postoperative pain care are provided to all.
Duration - Up to several hours post-surgery
Participants are monitored in the post-anesthesia care unit for opioid use, pain control, adverse events, and recovery progress for at least 60 minutes after surgery.
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
D A Finholt, J A Stirt, C A DiFazio...
https://pubmed.ncbi.nlm.nih.gov/3954094/Robert Chu, Nelly Umukoro, Tiashi Greer...
https://pubmed.ncbi.nlm.nih.gov/33633427/S Weibel, J Jokinen, N L Pace...
https://pubmed.ncbi.nlm.nih.gov/27199310/H R Ochs, M Knüchel, D R Abernethy...
https://pubmed.ncbi.nlm.nih.gov/6863582/Lukas G Keil, Mikaela H Sullivan, Sahil Dadoo...
https://pubmed.ncbi.nlm.nih.gov/34516466/Maciej Kaszyński, Dorota Lewandowska, Piotr Sawicki...
https://pubmed.ncbi.nlm.nih.gov/33397287/Keng Wah Foong, Pui San Loh, Sook Hui Chaw...
https://pubmed.ncbi.nlm.nih.gov/40021547/Jean-Xavier Mazoit, Bernard J Dalens
https://pubmed.ncbi.nlm.nih.gov/14715049/Pierre Pardessus, Maud Loiselle, Kelly Brouns...
https://pubmed.ncbi.nlm.nih.gov/39076006/Elizabeth A Hall, Hannah E Sauer, Margaret S Davis...
https://pubmed.ncbi.nlm.nih.gov/34036532/Nemours Children's Clinic
Lead Sponsor